SecProbe.io

CORRESP
1
filename1.htm

Genetic
Technologies Limited

60-66
Hanover Street

Fitzroy

Victoria
3065 Australia

May
21, 2020

EDGAR

Division
of Corporation Finance

Securities
and Exchange Commission

100
F Street, N.E.

Washington,
D.C. 20549

    Re:
    Genetic
    Technologies Limited

    Registration
    Statement on Form F-1

    File
    No. 333-235542

Ladies
and Gentlemen:

Pursuant
to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Genetic Technologies Limited (the
“Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated
so that it will become effective at 9:00 am., Eastern Time, on May 26, 2020, or as soon thereafter as possible.

The
Company hereby acknowledges the following:

    ●
    that
    should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose
    the Commission from taking any action with respect to the filing;

    ●
    the
    action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not
    relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

    ●
    the
    Company may not assert the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any
    person under the federal securities laws of the United States.

    Genetic
    Technologies Limited

    By:
    /s/
    Dr. Jerzy Muchnicki

    Title:
    Interim
    Chief Executive Officer